Evidence map›Paper›PMID 35102786›Full record

ArticleJournal of psychopharmacology (Oxford, England)2022

Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study.

Simon Jc Davies, David Rudoler, Claire de Oliveira, Anjie Huang, Paul Kurdyak, Andrea Iaboni

Open access · greenAbstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. A 21-year Comparative Study of Prescriptions of Benzodiazepines and Selective Serotonin Reuptake Inhibitors and Related Drugs in a Japanese University Hospital.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Optimizing treatment for older adults with depression.Therapeutic advances in psychopharmacology · 2023
    Review
  15. Potentially Inappropriate Medication Use in Patients with Dementia.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Simon Jc DaviesGeriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.ORCID 0000-0003-0095-5993
David RudolerCentre for Addiction and Mental Health, Toronto, ON, Canada.
Claire de OliveiraCentre for Addiction and Mental Health, Toronto, ON, Canada.
Anjie HuangICES, Toronto, ON, Canada.
Paul KurdyakDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.
Andrea IaboniDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-4268-6832
Centre for Addiction and Mental Health · CAUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBenzodiazepine treatment recommendations for older adults differ markedly between guidelines, especially their advice on the acceptability of long-term use.

aimsUsing population-based data we compared risks associated with chronic versus intermittent benzodiazepine usage in older adults. The primary outcome was falls resulting in hospital/emergency department visits.

methodsWe undertook a retrospective population-based cohort study using linked healthcare databases in adults aged ⩾ 66 years in Ontario, Canada, with a first prescription for benzodiazepines. Chronic and intermittent benzodiazepine users, based on the 180 days from index prescription, were matched (1:2 ratio) by sex, age and propensity score, then followed for up to 360 days. Hazard ratios (HRs) for outcomes were calculated from Cox regression models.

resultsA total of 57,041 chronic and 113,839 matched intermittent users were included. Hospitalization/emergency department visits for falls occurred during follow up in 4.6% chronic versus 3.2% intermittent users (HR = 1.13, 95% confidence interval (CI): 1.08 to 1.19;

conclusionOur study demonstrates evidence of significant excess risks associated with chronic benzodiazepine use compared to intermittent use. The excess risks may inform decision-making by older adults and clinicians about whether short- or long-term benzodiazepine use is a reasonable option for symptom management.

Indexed as

BenzodiazepinesHospitalizationAgedCohort StudiesHumansOntarioRetrospective StudiesBenzodiazepinesAnxiety disordersbenzodiazepinespharmacologypopulationside effects

Identifiers

PMID35102786
PMCPMC9066681
OpenAlexW4210697746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.